A Korean research team has developed a new viral vector technology that significantly improves the production efficiency of ...
The first vector-delivered gene therapies to receive FDA approval for clinical use were Luxturna,1 Spark Therapeutics’ vision loss cure, and Zolgensma,2 Novartis’ spinal muscular atrophy treatment.
Austin, United States, June 09, 2026 (GLOBE NEWSWIRE) -- "The Viral Vector Production (Research-use) Market was valued at USD 1.95 billion in 2025 and is projected to reach USD 8.26 billion by 2035, ...
Genetic engineering could be used to develop new, more effective production systems for viral vector producing cell lines.
Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced expansion of its global cell therapy manufacturing network to enable in-house viral vector production through a ...
After charting multiple personalized medicine expansions in recent years, contract manufacturer Charles River Laboratories is back with another gene therapy pact—this time centered on an ...
CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site, ...
Advances company’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing Mirus Bio’s leading GMP transfection reagents complement company’s upstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results